4//SEC Filing
PROVECTUS BIOPHARMACEUTICALS, INC. 4
Accession 0000899243-16-017260
$PVCTCIK 0000315545operating
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 7:35 PM ET
Size
18.1 KB
Accession
0000899243-16-017260
Insider Transaction Report
Form 4
CULPEPPER PETER R
Chief Financial Officer
Transactions
- Exercise Out-of-Money
Common Stock Warrants (right to buy)
2016-03-29+133,333→ 133,333 totalExercise: $0.85From: 2016-03-29Exp: 2020-06-19→ Common Stock (133,333 underlying) - Exercise Out-of-Money
Common Stock
2016-03-29$1.00/sh+133,333$133,333→ 1,384,496 total - Exercise Out-of-Money
Common Stock
2016-03-29$1.00/sh+106,000$106,000→ 296,503 total(indirect: By 401(k)) - Exercise Out-of-Money
Common Stock Warrants (right to buy)
2016-03-29+133,333→ 133,333 totalExercise: $0.85From: 2016-03-29Exp: 2020-06-19→ Common Stock (133,333 underlying) - Exercise Out-of-Money
Common Stock
2016-03-29$1.00/sh+27,333$27,333→ 1,411,829 total - Exercise Out-of-Money
Common Stock Warrants (right to buy)
2016-03-29−133,333→ 0 totalExercise: $1.00From: 2012-11-16Exp: 2017-11-16→ Common Stock (133,333 underlying) - Exercise Out-of-Money
Common Stock Warrants (right to buy)
2016-03-29−133,333→ 0 totalExercise: $1.00From: 2012-12-03Exp: 2017-12-03→ Common Stock (133,333 underlying)
Footnotes (1)
- [F1]On March 29, 2016, the reporting person exercised 266,666 warrants pursuant to the Issuer's warrant exchange offer, at a discounted exercise price of $0.50 per share, which exercise consisted of: (i) an exercise of 133,333 shares pursuant to a warrant issued on November 16, 2012, with an original exercise price of $1.00 per share and (ii) an exercise of 133,333 shares pursuant to a warrant issued on December 3, 2012, with an original exercise price of $1.00 per share. Under the terms of the warrant exchange offer, holders received, in addition to the common stock acquired upon exercise of their existing warrants, an equal number of new warrants to purchase the same number of shares of the Issuer's common stock at an exercise price of $0.85 per share that will expire June 19, 2020.
Documents
Issuer
PROVECTUS BIOPHARMACEUTICALS, INC.
CIK 0000315545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000315545
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 7:35 PM ET
- Size
- 18.1 KB